Small Lung Tumours: High Risk Lesions and Contraindications to Stereotactic Ablative Body Radiotherapy (SABR)

被引：0
|
作者：
Ball, D. [1 ]
机构：
[1] Peter MacCallum Canc Ctr, Radiat Oncol, Melbourne, Vic, Australia
来源：
JOURNAL OF THORACIC ONCOLOGY | 2018年 / 13卷 / 10期
关键词：
Stereotactic ablative radiotherapy; contraindications;
D O I：
10.1016/j.jtho.2018.08.080
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
MTE24.02
引用
收藏
页码：S225 / S226
页数：2
相关论文
共 50 条
  • [31] Quantification of interplay and gradient effects for lung stereotactic ablative radiotherapy (SABR) treatments
    Tyler, Madelaine K.
    JOURNAL OF APPLIED CLINICAL MEDICAL PHYSICS, 2016, 17 (01): : 158 - 166
  • [32] TREATMENT OF MULTIPLE PRIMARY LUNG CANCERS (MPLC) WITH STEREOTACTIC ABLATIVE RADIOTHERAPY (SABR)
    Griffioen, Gwendolyn H.
    Lagerwaard, Frank
    Haasbeek, Cornelis J.
    Smit, Egbert
    Slotman, Ben J.
    Senan, Suresh
    JOURNAL OF THORACIC ONCOLOGY, 2013, 8 : S839 - S839
  • [33] Lung stereotactic ablative radiotherapy (SABR): dosimetric considerations for chest wall toxicity
    Murray, Louise
    Karakaya, Ebru
    Hinsley, Samantha
    Naisbitt, Mitchell
    Lilley, John
    Snee, Michael
    Clarke, Katy
    Musunuru, Hima B.
    Ramasamy, Satiavani
    Turner, Rob
    Franks, Kevin
    BRITISH JOURNAL OF RADIOLOGY, 2016, 89 (1058):
  • [34] Stereotactic ablative body radiotherapy (SABR): an alternative to surgery in stage I-II non-small-cell cancer of the lung?
    Mirimanoff, Rene-Olivier
    CHINESE CLINICAL ONCOLOGY, 2015, 4 (04)
  • [35] PEARL: Pathologic Effect of NeoAdjuvant Stereotactic Ablative Body Radiotherapy (SABR) in Operable Early Stage Lung Cancer
    Van Meerbeeck, Jan P.
    Vandecasteele, Katrien
    Tournoy, Kurt
    Vermaelen, Karim Y.
    De Ryck, Frederic
    Surmont, Veerle F.
    JOURNAL OF THORACIC ONCOLOGY, 2015, 10 (09) : S680 - S680
  • [36] Stereotactic ablative body radiotherapy (SABR) for early lung cancer: implementation and outcomes at University College London Hospital
    Osborn, K.
    Ahmed, M.
    Allington, L.
    Haji, N.
    Mendes, R.
    LUNG CANCER, 2014, 83 : S61 - S61
  • [37] Outcomes for Stereotactic Ablative Body Radiotherapy (SABR) for Early Primary Lung Cancers: Cyberknife Versus VMAT Platform
    Allos, B.
    Mascall, S.
    Vreugdenhil, M.
    Watkins, S.
    Stevenson, R.
    Ghafoor, Q.
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (11) : S2180 - S2180
  • [38] Quality of Life and Symptoms in Patients Undergoing Stereotactic Ablative Body Radiotherapy (SABR) for Early Stage Lung Cancer
    Gray, C.
    Wingate, E.
    Ghafoor, Q.
    CLINICAL ONCOLOGY, 2018, 30 (06) : E56 - E56
  • [39] IAEA RCA 6065: IMPROVING ACCESS TO STEREOTACTIC ABLATIVE BODY RADIOTHERAPY (SABR) FOR LUNG CANCER PATIENTS IN ASIA
    Hegi-Johnson, Fiona
    Siva, Shankar
    Foote, Matthew
    Tan, Daniel
    Kim, Mi-Sook
    JOURNAL OF THORACIC ONCOLOGY, 2013, 8 : S1130 - S1130
  • [40] Clinical outcomes of stereotactic ablative body radiotherapy (SABR) in medically inoperable early stage lung cancer patients
    Groves, Jonathan
    Yeo, Ryan
    Tsang, Yat
    Shah, Nihal
    Win, Thida
    EUROPEAN RESPIRATORY JOURNAL, 2021, 58
12345